BIVALENT TICK FEVER VACCINE

Krajina: Austrália

Jazyk: angličtina

Zdroj: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Kúpte ho teraz

Príbalový leták Príbalový leták (PIL)
16-06-1997

Aktívna zložka:

BABESIA BOVIS; ANAPLASMA CENTRALE

Dostupné z:

DEPARTMENT OF AGRICULTURE AND FISHERIES

INN (Medzinárodný Name):

Anaplasma centrale(10000000u/dose)+Babesia bovis(10000000u/dose)

Forma lieku:

MISC. VACCINES OR ANTI SERA

Zloženie:

BABESIA BOVIS VACCINE-MICROBIAL Active 0.0 P; ANAPLASMA CENTRALE VACCINE-VIRAL Active 0.0 P

Počet v balení:

20mL-200mL

Trieda:

VP - Veterinary Pesticide

Výrobca:

DEPT AGRICULTURE, FI

Terapeutické skupiny:

CATTLE | BEEF | BOS INDICUS | BOS TAURUS | BOVINE | BUFFALO | BULL | BULLOCK | CALF | COW | DAIRY COW | HEIFER | STEER

Terapeutické oblasti:

IMMUNOTHERAPY

Terapeutické indikácie:

TICK FEVER - BOVINE ANAPLASMOSIS | TICK FEVER - BOVINE BABESIOSIS | VACCINE | ANAPLASMA MARGINALE | BABESIA BIGEMINA | BABESIA BOVIS | EQUINE ROTAVIRUS | RED WATER | REDWATER

Prehľad produktov:

Poison schedule: 0; Withholding period: WHP: Nil; Host/pest details: CATTLE: [TICK FEVER - BOVINE ANAPLASMOSIS, TICK FEVER - BOVINE BABESIOSIS, VACCINE]; For control of tick fever (Babesiosis & Anaplasmosis) in cattle.This product is contraindicated for use in cattle during late pregnancy. Caution: Avoid carcass damage. See PRECAUTIONS, etc. on label also.

Stav Autorizácia:

Registered

Dátum Autorizácia:

2023-07-01

Príbalový leták

                                FOR ANIMAL TREATMENT ONLY
_BIVALENT TICK FEVER VACCINE_
_Contains B bovis 1 x 10_
_7_
_,_
_A centrale 1 x 10_
_7_
_ organisms per dose_
FOR CONTROL OF TICK FEVER IN CATTLE
READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT
If accidental self-injection occurs, seek medical advice
Dose: 2mL. For subcutaneous or intramuscular injection
WITHHOLDING PERIOD NIL
EXPIRY DATE:
B
Store between 2°C to 8°C (Refrigerate. DO NOT FREEZE)
Tick Fever Centre,
280 Grindle Rd, Wacol, QLD 4076
File name
49715_
20-200mL_immediate_MPL_V02.pdf
Dimensions
95mm X 50mm
Scale
100%
Date
21/05/08 V02
APVMA
49715/20–200mL/0508
20–200mL
BIV 010–100
PANTONE 288
PANTONE 285
PANTONE 1505
4507 _6
6
APPROVED
LABEL
Info
PEST

Verified
FOR ANIMAL TREATMENT ONLY
BIVALENT TICK FEVER VACCINE
BIVALENT VACCINE CONTAINS:
_BABESIA BOVIS_ 1 X 10
7 ORGANISMS PER DOSE
_ANAPLASMA CENTRALE_ 1 X 10
7 ORGANISMS PER DOSE
FOR CONTROL OF TICK FEVER (BABESIOSIS
AND ANAPLASMOSIS) IN CATTLE
This vaccine contains live attenuated strains of tick fever
organisms. One vaccination is usually sufficient to provide
life long immunity against natural tick fever infections.
Immunity to both parasites develops within 8 weeks of
administration of the vaccine.
_This vaccine is registered with the Australian Pesticides _
_and Veterinary Medicines Authority (Reg. No 49715) _
_and is manufactured in compliance with the Australian _
_Code of Good Manufacturing Practice for Veterinary _
_Preparations._
TICK FEVER CENTRE
280 GRINDLE RD.,
WACOL, QLD 4076, AUSTRALIA
TELEPHONE: (07) 3898 9655
FAX NO: (07) 3898 9685
E-MAIL: TFC@DPI.QLD.GOV.AU
DIRECTIONS FOR USE
Restrictions apply on the use of imidocarb in lactating
dairy cattle.
Restrictions also apply to the supply of oxytetracycline; contact
a veterinarian if this drug is to be used.
AFTER CARE
Cattle should have access to good feed, shade and water
during and after the expected reaction periods. Stress should
be avoided.
WITHHOLDING PERIOD
Nil; however, carcass quality could be affected by fever if
animals are slaughtered during
                                
                                Prečítajte si celý dokument
                                
                            

Súhrn charakteristických

                                _TICK FEVER CENTRE, WACOL _
_MSDS BIVALENT _
MATERIAL SAFETY DATA SHEET 
BIVALENT TICK FEVER VACCINE 
 
 
_REF: MSDS 2 _
_ _
_ _
Rev: 6 
Date of Issue:  4/09/08 
Page 1 of 5 
 
Department of Primary Industries and Fisheries, Queensland 
Biosecurity 
Tick Fever Centre 
280 Grindle Road, Wacol  Queensland  4076  Australia 
 
Telephone:  +61 7 3898 9655 
 
Fax:  +61 7 3898 9685 
 E-mail: 
 
tfc@dpi.qld.gov.au
 
Web-site: http://www.dpi.qld.gov.au/tickfever/
 
 
IDENTIFICATION 
 
PRODUCT NAME
: 
  BIVALENT 
TICK FEVER VACCINE 
 
 
 
 
 
 
 
OTHER NAMES: 
 
 
Bivalent chilled vaccine 
 
MANUFACTURER’S PRODUCT CODE
: 
BIV/10, 20, 25, 50, 100. 
 
UN 
NUMBER: 
   None allocated 
 
DANGEROUS GOODS CLASS AND  
None allocated, no subsidiary risk 
SUBSIDIARY RISK 
 
HAZCHEM CODE: 
 
 
None allocated 
 
POISONS SCHEDULE NUMBER:   
Not scheduled 
 
USE:   
 
 
 
For control of Tick Fever (Bovine Babesiosis and    
 
 
 
 
 
Anaplasmosis) by vaccination in cattle. 
 
PHYSICAL DESCRIPTION/PROPERTIES: 
 
APPEARANCE: 
   Liquid blood based vaccine packed in polypropylene  
     pillow 
packs 
 
BOILING 
POINT 
   No data.  Expected to be about 100
0
C 
 
VAPOUR PRESSURE: 
 
 
No data 
 
SPECIFIC GRAVITY: 
 
 
Approximately 0.97 
 
FLAMMABILITY:     Does not burn 
 
CORROSIVENESS:     Not corrosive 
 
 
 
_TICK FEVER CENTRE, WACOL _
_MSDS BIVALENT _
MATERIAL SAFETY DATA SHEET 
BIVALENT TICK FEVER VACCINE 
 
 
_REF: MSDS 2 _
_ _
_ _
Rev: 6 
Date of Issue:  4/09/08 
Page 2 of 5 
 
OTHER PROPERTIES: 
 
INGREDIENTS: 
   Contains live attenuated tick fever organisms (_Babesia bovis_ 
 
 
 
_and Anaplasma centrale_) in bovine blood diluted with a cell 
free diluent. The diluent consists of 10% bovine serum in an 
isotonic balanced salt solution. 
 
 
 
 
 
 
     Each 
2 
mL 
dose 
of 
bivalent vaccine contains:  
 
     (i) 
Mixed
                                
                                Prečítajte si celý dokument